Clinical Trial

A Study of BBT002 in Healthy Volunteers (HVs) and in Adult Patients With Chronic Obstructive Pulmonary Disease (COPD) or Chronic Rhiosininusitis With Nasal Polyps (CRSwNP)

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
Randomized study of single and multiple doses of BBT002 in healthy volunteers and in adult patients with chronic obstructive pulmonary disease (COPD) or chronic rhinosinusitis with nasal polyps (CRSwNP).
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-04-18; most recent amendment 2026-06-28.
Status change: Not Yet Recruiting → Recruiting 2025-05-09
Trial Details
NCT Number NCT06944925
Lead Sponsor Bambusa Therapeutics
Conditions Chronic Obstructive Pulmonary Disease
Enrollment 286 participants
Start Date 2025-05-08
Primary Completion 2027-01-31 (estimated)
Study Completion 2027-07-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-01